-
2023-504993-40-00
5
2024-02-14
Human immunodeficiency virus (HIV)
-
2023-503288-40-00
5
2024-01-26
Unresectable or Metastatic Melanoma
-
2023-503428-24-00
4
2024-01-19
Neoplasms, Head and Neck
-
2023-505023-31-00
5
2023-11-17
Renal cell carcinoma
-
2022-502102-32-00
5
2023-11-16
Primary Immunoglobulin A (IgA) Nephropathy
-
2022-501863-41-00
5
2023-11-13
Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non–Small
-
2022-503004-24-00
5
2023-10-20
Influenza virus
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-501024-20-00
5
2023-07-25
ER+/HER2- Early Breast Cancer
-
2022-501576-25-00
5
2023-07-07
Melanoma
-
2022-502977-41-00
5
2023-06-23
Non-Small Cell Lung Cancer
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2024-510742-13-00
5
2023-04-19
Pediatric low-grade glioma harboring an activating RAF alteration requ
-
2024-512785-33-00
10
2023-03-01
Active Idiopathic Inflammatory Myopathy (IIM)
-
2023-506924-94-00
5
2023-02-28
Cardiovascular disease
-
2022-501744-15-00
5
2023-01-23
Obesity, Overweight
-
2023-504027-78-00
4
2023-01-13
Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
-
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
-
2023-504743-13-00
4
2022-11-30
Moderately to Severely Active Ulcerative Colitis
-
2024-511581-37-00
6
2022-11-25
Respiratory Tract Infections with Wheezing Lower Respiratory Illness
-
2023-505772-30-00
5
2022-11-09
Melanoma
-
2023-505628-67-00
5
2022-10-28
Relapsed and Refractory Follicular Lymphoma
-
2023-503467-41-00
5
2022-10-12
Relapsed or Refractory Multiple Myeloma
-
2024-515557-22-00
6
2022-10-01
Juvenile Idiopathic Arthritis